Table: RaQualia Pharma -2021 group results

RaQualia Pharma

14/02/2022 06:30

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             2.78            1.11           2.61                  
                (+150.7 pct)     (-35.0 pct)    (-6.2 pct)               
  Operating        707 mln      loss 486 mln      420 mln                
                                                (-40.6 pct)              
  Recurring        863 mln      loss 527 mln      420 mln                
                                                (-51.3 pct)              
  Net
  Net              755 mln      loss 606 mln      342 mln                
                                                (-54.7 pct)              
  EPS             36.07 yen    loss 28.97 yen    16.34 yen               
  EPS Diluted     36.04 yen                                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T